AI assistant
ABBOTT LABORATORIES — Director's Dealing 2025
Dec 19, 2025
29777_dirs_2025-12-19_5331f7f8-da0a-4cfc-be44-2d2b011227ae.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2025-12-12
Reporting Person: Scoggins Christopher J (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 63621 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option (right to buy) | $75.9 | 2029-02-21 | Common shares (51557) | Direct | |
| Option (right to buy) | $79.98 | 2029-03-31 | Common shares (43388) | Direct | |
| Option (right to buy) | $87.72 | 2030-02-20 | Common shares (68578) | Direct | |
| Option (right to buy) | $124.04 | 2031-02-18 | Common shares (63991) | Direct | |
| Option (right to buy) | $117.58 | 2032-02-17 | Common shares (48852) | Direct | |
| Option (right to buy) | $106.24 | 2033-02-16 | Common shares (37483) | Direct | |
| Option (right to buy) | $116.98 | 2034-02-20 | Common shares (31721) | Direct | |
| Option (right to buy) | $135.42 | 2035-02-24 | Common shares (45730) | Direct |
Footnotes
F1: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
F2: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,494 on February 17, 2024, 12,494 on February 17, 2025, and 12,495 on February 17, 2026.
F3: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,573 on February 21, 2025, 10,574 on February 21, 2026, and 10,574 on February 21, 2027.
F4: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,243 on February 25, 2026, 15,243 on February 25, 2027, and 15,244 on February 25, 2028.